Clinical trial
PHARM-MD; An Open-Label, Randomized Controlled Phase II Study to Evaluate the Efficacy of a Pharmacist Managed Diabetes Clinic in High-Risk Diabetes Patients
NCT03377127 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PHARM-MD; An Open-Label, Randomized Controlled Phase II Study to Evaluate the Efficacy of a Pharmacist Managed Diabetes Clinic in High-Risk Diabetes Patients
- Lead sponsor
- Corewell Health East
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 19, 2018
- Completion date
- November 30, 2020
- Enrollment
- 86 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.